The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
EASL Clinical Practice Guidelines: Wilson’s disease
Open accessAbstract
This Clinical Practice Guideline (CPG) has been developed to assist physicians and other healthcare providers in the diagnosis and management of patients with Wilson's disease. The goal is to describe a number of generally accepted approaches for diagnosis, prevention, and treatment of Wilson's disease. Recommendations are based on a systematic literature review in the Medline (PubMed version), Embase (Dialog version), and the Cochrane Library databases using entries from 1966 to 2011. The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) system used in other EASL CPGs was used and set against the somewhat different grading system used in the AASLD guidelines (Table 1A and B). Unfortunately, there is not a single randomized controlled trial conducted in Wilson's disease which has an optimal design. Thus, it is impossible to assign a high or even a moderate quality of evidence to any of the questions dealt with in these guidelines. The evaluation is mostly based on large case series which have been reported within the last decades.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Cousins, R. J. (1985) · Physiological Reviews · doi:10.1152/physrev.1985.65.2.238 · Cited by 1,326
Nitric Oxide Scavenging by Curcuminoids
Sreejayan, & Rao, M. N. A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06761.x · Cited by 1,135
Diagnosis and phenotypic classification of Wilson disease1
Ferenci, P., Caca, K., Loudianos, G., Mieli‐Vergani, G., Tanner, S., Sternlieb, I., Schilsky, M., Cox, D., & Berr, F. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.00824.x · Cited by 927
Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study
Merle, U., Schaefer, M., Ferenci, P., & Stremmel, W. (2007) · Gut · doi:10.1136/gut.2005.087262 · Cited by 625
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.
Pan, Q., Kleer, C. G., van Golen, K. L., Irani, J., Bottema, K. M., Bias, C., Carvalho, M. D., Mesri, E. A., Robins, D. M., Dick, R. D., et al. (2002) · PubMed · Cited by 500
Wilson's disease in children: 37-Year experience and revised King's score for liver transplantation
Dhawan, A., Taylor, R. M., Cheeseman, P., De Silva, P., Katsiyiannakis, L., & Mieli-Vergani, G. (2005) · Liver Transplantation · doi:10.1002/lt.20352 · Cited by 441
Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide
Lang, P. A., Schenck, M., Nicolay, J. P., Becker, J. U., Kempe, D. S., Lupescu, A., Koka, S., Eisele, K., Klarl, B. A., Rübben, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1539 · Cited by 438
TREATMENT OF WILSON'S DISEASE WITH TRIENTINE (TRIETHYLENE TETRAMINE) DIHYDROCHLORIDE
Walshe, J. M. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92201-2 · Cited by 378
Gitlin, J. D. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.05.010 · Cited by 343
Brewer, G. J., Terry, C. A., Aisen, A. M., & Hill, G. M. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520170020016 · Cited by 335
Brewer, G. J., Askari, F., Lorincz, M. T., Carlson, M., Schilsky, M., Kluin, K. J., Hedera, P., Moretti, P., Fink, J. K., Tankanow, R., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.521 · Cited by 322
Brewer, G. J., Hedera, P., Kluin, K. J., Carlson, M., Askari, F., Dick, R. B., Sitterly, J., & Fink, J. K. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.379 · Cited by 308
Korman, J. D., Volenberg, I., Balko, J., Webster, J., Schiodt, F. V., Squires, R. H., Fontana, R. J., Lee, W. M., & Schilsky, M. L. (2008) · Hepatology · doi:10.1002/hep.22446 · Cited by 305
Wilson Disease: Clinical Presentation, Treatment, and Survival
Stremmel, W., Meyerrose, K.-W., Niederau, C., Hefter, H., Kreuzpaintner, G., & Strohmeyer, G. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-720 · Cited by 303
Liver transplantation for Wilson’s disease: Indications and outcome
Schilsky, M. L., Scheinberg, H. I., & Sternlieb, I. (1994) · Hepatology · doi:10.1002/hep.1840190307 · Cited by 293
Strand, S., Hofmann, W. J., Grambihler, A., Hug, H., Volkmann, M., Otto, G., Wesch, H., Mariani, S. M., Hack, V., Stremmel, W., et al. (1998) · Nature Medicine · doi:10.1038/nm0598-588 · Cited by 278
Ferenci, P., Członkowska, A., Merle, U., Ferenc, S., Gromadzka, G., Yurdaydin, C., Vogel, W., Bruha, R., Schmidt, H. T., & Stremmel, W. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.057 · Cited by 271
Ferenci, P. (2006) · Human Genetics · doi:10.1007/s00439-006-0202-5 · Cited by 271
Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis
Harris, Z., Klomp, L., & Gitlin, J. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.972s · Cited by 256
Wilson's disease: clinical presentation and use of prognostic index.
Nazer, H., Ede, R. J., Mowat, A. P., & Williams, R. (1986) · Gut · doi:10.1136/gut.27.11.1377 · Cited by 256
Diagnosis of Wilson's disease: an experience over three decades
Gow, P. J., Smallwood, R. A., Angus, P. W., Smith, A. L., Wall, A. J., & Sewell, R. B. (2000) · Gut · doi:10.1136/gut.46.3.415 · Cited by 251
Oral zinc therapy for Wilson's disease
BREWER, G. J., HILL, G. M., PRASAD, A. S., COSSACK, Z. T., & RABBANI, P. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-314 · Cited by 244
Barik, A., Mishra, B., Shen, L., Mohan, H., Kadam, R. M., Dutta, S., Zhang, H.-Y., & Priyadarsini, K. I. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.005 · Cited by 235
Lutsenko, S., & Petris, M. J. (2003) · Journal of Membrane Biology · doi:10.1007/s00232-002-1040-6 · Cited by 218
Zinc Monotherapy Is Not as Effective as Chelating Agents in Treatment of Wilson Disease
Weiss, K. H., Gotthardt, D. N., Klemm, D., Merle, U., Ferenci–Foerster, D., Schaefer, M., Ferenci, P., & Stremmel, W. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.034 · Cited by 217
Treatment of Wilson’s disease with zinc. XVII: Treatment during pregnancy
Brewer, G. J., Johnson, V. D., Dick, R. D., Hedera, P., Fink, J. K., & Kluin, K. J. (2000) · Hepatology · doi:10.1002/hep.510310216 · Cited by 208
Scheinberg, I. H., Jaffe, M. E., & Sternlieb, I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170405 · Cited by 208
Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation
Alvarez, H. M., Xue, Y., Robinson, C. D., Canalizo-Hernández, M. A., Marvin, R. G., Kelly, R. A., Mondragón, A., Penner-Hahn, J. E., & O’Halloran, T. V. (2010) · Science · doi:10.1126/science.1179907 · Cited by 204
Sokol, R. J., Twedt, D., McKim, J. M., Devereaux, M. W., Karrer, F. M., Kam, I., Von Steigman, G., Narkewicz, M. R., Bacon, B. R., Britton, R. S., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90822-2 · Cited by 203
Brewer, G. J., Askari, F., Dick, R. B., Sitterly, J., Fink, J. K., Carlson, M., Kluin, K. J., & Lorincz, M. T. (2009) · Translational Research · doi:10.1016/j.trsl.2009.05.002 · Cited by 190
Hepatic Copper Metabolism: Insights From Genetic Disease
Tao, T. Y., & Gitlin, J. D. (2003) · Hepatology · doi:10.1053/jhep.2003.50281 · Cited by 182
Effects of long-term treatment in Wilson's disease withd-penicillamine and zinc sulphate
Czlonkowska, A., Gajda, J., & Rodo, M. (1996) · Journal of Neurology · doi:10.1007/bf00868525 · Cited by 182
Mitochondrial and Fatty Changes in Hepatocytes of Patients with Wilson's Disease
Sternlieb, I. (1968) · Gastroenterology · doi:10.1016/s0016-5085(19)34045-4 · Cited by 180
WIGGELINKHUIZEN, M., TILANUS, M. E. C., BOLLEN, C. W., & HOUWEN, R. H. J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.03959.x · Cited by 173
Brewer, G. J. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540180023009 · Cited by 167
Loudianos, G., Dessi, V., Lovicu, M., Angius, A., Figus, A., Lilliu, F., De Virgiliis, S., Nurchi, A. M., Deplano, A., Moi, P., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(199910)14:4<294::aid-humu4>3.0.co;2-9 · Cited by 166
Wilson disease: findings at MR imaging and CT of the brain with clinical correlation.
van Wassenaer-van Hall, H. N., van den Heuvel, A. G., Algra, A., Hoogenraad, T. U., & Mali, W. P. (1996) · Radiology · doi:10.1148/radiology.198.2.8596862 · Cited by 165
Diagnosis and current therapy of Wilson's disease
Ferenci, P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01813.x · Cited by 162
Histology of the Liver in Wilson’s Disease: A Study of 34 Cases
Stromeyer, F. W., & Ishak, K. G. (1980) · American Journal of Clinical Pathology · doi:10.1093/ajcp/73.1.12 · Cited by 153
Diagnosis and Management of Wilson's Disease
Medici, V., Trevisan, C. P., Renata D'Incà, et al. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225670.91722.59 · Cited by 151
Chelation treatment of neurological Wilson's disease
Walshe, J. M., & Yealland, M. (1993) · QJM · doi:10.1093/oxfordjournals.qjmed.a068791 · Cited by 148
Ceruloplasmin: The Copper Transport Protein With Essential Oxidase Activity
Frieden, E., & Hsieh, H. (1976) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470122891.ch6 · Cited by 146
Effect of foodstuffs on the absorption of zinc sulfate
Pécoud, A., Donzel, P., & Schelling, J. L. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975174469 · Cited by 141
Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin
Cauza, E., Maier-Dobersberger, T., Polli, C., Kaserer, K., Kramer, L., & Ferenci, P. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80182-1 · Cited by 138
Oral Zinc Sulphate as Long-Term Treatment in Wilson’s Disease (Hepatolenticular Degeneration)
Hoogenraad, T. U., Koevoet, R., & Korver, E. G. W. M. D. R. (2008) · European Neurology · doi:10.1159/000115077 · Cited by 136
Pregnancy in Penicillamine-Treated Patients with Wilson's Disease
Scheinberg, I. H., & Sternlieb, I. (1975) · New England Journal of Medicine · doi:10.1056/nejm197512182932507 · Cited by 135
Wilson's disease, presenting as chronic active hepatitis
Scott, J., Gollan, J. L., Samourian, S., & Sherlock, S. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90238-x · Cited by 133
von Herbay, A., de GROOT, H., Hegi, U., Stremmel, W., Strohmeyer, G. W., & Sies, H. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80465-9 · Cited by 131
Neurologically Presenting Wilson???s Disease
Brewer, G. J. (2005) · CNS Drugs · doi:10.2165/00023210-200519030-00001 · Cited by 126
Członkowska, A., Tarnacka, B., Möller, J. C., Leinweber, B., Bandmann, O., Woimant, F., & Oertel, W. H. (2007) · PubMed · Cited by 124
Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease
Walter, U., Krolikowski, K., Tarnacka, B., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000161847.46465.b9 · Cited by 122
Iron accumulation in the liver of male patients with Wilson's disease
Shiono, Y., Wakusawa, S., Hayashi, H., Takikawa, T., Yano, M., Okada, T., Mabuchi, H., Kono, S., & Miyajima, H. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05269.x · Cited by 120
Ferenci, P. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00484-2 · Cited by 115
The Liver Biopsy Diagnosis of Wilson’s Disease:Methods in Pathology
Ludwig, J., Moyer, T. P., & Rakela, J. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.4.443 · Cited by 114
Wilson’s disease—cause of mortality in 164 patients during 1992–2003 observation period
Członkowska, A., Tarnacka, B., Litwin, T., Gajda, J., & RODO, M. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0720-4 · Cited by 112
Arthropathy of Wilson's disease. Study of clinical and radiological features in 32 patients.
Golding, D. N., & Walshe, J. M. (1977) · Annals of the Rheumatic Diseases · doi:10.1136/ard.36.2.99 · Cited by 112
Long-term exclusive zinc monotherapy in symptomatic Wilson disease: Experience in 17 patients #
Linn, F. H. H., Houwen, R. H. J., van Hattum, J., van der Kleij, S., & van Erpecum, K. J. (2009) · Hepatology · doi:10.1002/hep.23182 · Cited by 111
A High Index of Suspicion: The Key to an Early Diagnosis of Wilson's Disease in Childhood
Sánchez‐Albisua, I., Garde, T., Hierro, L., Camarena, C., Frauca, E., Vega, A. D. L., Díaz, M. C., Larrauri, J., & Jara, P. (1999) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1999.tb02036.x · Cited by 109
PENICILLAMINE MAY DETOXIFY COPPER IN WILSON'S DISEASE
Scheinberg, I. H., Sternlieb, I., Schilsky, M. L., & Stockert, R. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92753-x · Cited by 109
Kukkle, P. L., Sinha, S., Taly, A. B., & Vasudev, M. K. (2010) · Movement Disorders · doi:10.1002/mds.22689 · Cited by 103
Lipsky, P. E., & Ziff, M. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.3.1006 · Cited by 102
Neuropsychiatric aspects of treated Wilson's disease
Svetel, M. V., Potrebić, A., Pekmezović, T., Tomić, A., Kresojević, N. D., Ješić, R., Dragašević, N., & Kostić, V. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.01.010 · Cited by 101
Roberts, E. A., & Cox, D. W. (1998) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(98)90133-6 · Cited by 97
Arnon, R., Annunziato, R. A., Schilsky, M. L., Miloh, T., Willis, A., Sturdevant, M. L., Sakworawich, A., Suchy, F. J., & Kerkar, N. N. (2010) · Clinical Transplantation · doi:10.1111/j.1399-0012.2010.01327.x · Cited by 97
Collagen cross-linking. Effect of D-penicillamine on cross-linking in vitro.
Siegel, R. C. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32825-9 · Cited by 96
Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease
Seniów, J. B., Bak, T., Gajda, J., et al. (2002) · Movement Disorders · doi:10.1002/mds.10195 · Cited by 95
Merle, U., Eisenbach, C., Weiss, K. H., Tuma, S., & Stremmel, W. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.022 · Cited by 95
Successful medical treatment of severely decompensated Wilson disease
Silva, E. S., Sarles, J., Buts, J. P., et al. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70412-2 · Cited by 93
Loudianos, G., Dessi, V., Lovicu, M., et al. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.11.833 · Cited by 91
Abnormalities in tests of copper metabolism in primary sclerosing cholangitis
Gross, J. B., Ludwig, J., Wiesner, R. H., McCall, J., & LaRusso, N. F. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90326-9 · Cited by 87
The Management of Pregnancy in Wilson's Disease Treated with Trientine
Walshe, J. M. (1986) · QJM · doi:10.1093/oxfordjournals.qjmed.a067943 · Cited by 85
Long-Term Outcomes for 32 Cases of Wilson’s Disease After Living-Donor Liver Transplantation
Yoshitoshi, E. Y., Takada, Y., Oike, F., Sakamoto, S., Ogawa, K., Kanazawa, H., Ogura, Y., Okamoto, S., Haga, H., Ueda, M., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181919984 · Cited by 81
Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
Brewer, G. J., Yuzbasiyan‐Gurkan, V., Lee, D. Y., & Appelman, H. D. (1989) · PubMed · Cited by 79
Brewer, G. J., Yuzbasiyan‐Gurkan, V., & Young, A. B. (1987) · Seminars in Neurology · doi:10.1055/s-2008-1041420 · Cited by 75
Myasthenia syndrome during penicillamine treatment.
Członkowska, A. (1975) · BMJ · doi:10.1136/bmj.2.5973.726-a · Cited by 50
Liver transplantation in neurologic Wilson’s disease
Schumacher, G., Platz, K. P., Mueller, A. R., Neuhaus, R., Luck, W., Langrehr, J. M., Settmacher, U., Steinmueller, T., Becker, M., & Neuhaus, P. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)02578-1 · Cited by 46
Sarkar, B., SASS-KORTSAK, A. M., Clarke, R., Laurie, S. H., & Wei, P. (1977) · Proceedings of the Royal Society of Medicine · doi:10.1177/00359157770700s307 · Cited by 44
Triethylene-Tetramine(Trien) Therapy for Wilson's Disease.
Saito, H., Watanabe, K., SAHARA, M., Mochizuki, R., Edo, K., & Ohyama, Y. (1991) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.164.29 · Cited by 42
Bioavailability and pharmacokinetics of D-penicillamine.
Kukovetz, W. R., Beubler, E., Kreuzig, F., et al. (1983) · PubMed · Cited by 41
Karunajeewa, H., Wall, A. J., METZ, J., et al. (1998) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1998.tb02975.x · Cited by 34
Transcranial Sonography in Brain Disorders with Trace Metal Accumulation
Walter, U. (2010) · International review of neurobiology · doi:10.1016/s0074-7742(10)90012-3 · Cited by 33
Borthwick, T., Benson, G. D., & Schugar, H. J. (1980) · PubMed · Cited by 31
Adverse reaction after tetrathiomolybdate treatment for Wilson's disease: A case report
Medici, V., Trevisan, C. P., Bigotto, M. A., et al. (2006) · Movement Disorders · doi:10.1002/mds.21109 · Cited by 20
Indian Childhood Cirrhosis and Tyrolean Childhood Cirrhosis
Tanner, M. S. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4859-1_11 · Cited by 20
Potential of vitamin E as an antioxidant adjunct in Wilson’s disease
Fryer, M. J. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.05.025 · Cited by 17
Adjunctive Vitamin E Treatment in Wilson Disease and Suggestions for Future Trials
Shen, L., & Ji, H. (2010) · Hepatology · doi:10.1002/hep.23665 · Cited by 12
Cited by
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Wilson's disease and other neurological copper disorders
Bandmann, O., Weiss, K. H., & Kaler, S. G. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70190-5 · Cited by 1,036
Członkowska, A., Litwin, T., Dusek, P., Ferenci, P., Lutsenko, S., Medici, V., Rybakowski, J. K., Weiss, K. H., & Schilsky, M. L. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0018-3 · Cited by 913
Metadata
- Authors
- European Association for the Study of the Liver
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 56
- Issue
- 3
- Pages
- 671-685
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4211041131
- Cited by
- 1,243
- References
- 87
- FWCI
- 45.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.